KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Biomarin Pharmaceutical (BMRN) Asset Utilization Ratio (2017 - 2025)

Historic Asset Utilization Ratio for Biomarin Pharmaceutical (BMRN) over the last 17 years, with Q3 2025 value amounting to 0.41.

  • Biomarin Pharmaceutical's Asset Utilization Ratio rose 379.66% to 0.41 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.41, marking a year-over-year increase of 379.66%. This contributed to the annual value of 0.41 for FY2024, which is 1273.21% up from last year.
  • Latest data reveals that Biomarin Pharmaceutical reported Asset Utilization Ratio of 0.41 as of Q3 2025, which was up 379.66% from 0.42 recorded in Q2 2025.
  • In the past 5 years, Biomarin Pharmaceutical's Asset Utilization Ratio registered a high of 0.42 during Q2 2025, and its lowest value of 0.31 during Q4 2021.
  • For the 5-year period, Biomarin Pharmaceutical's Asset Utilization Ratio averaged around 0.35, with its median value being 0.34 (2023).
  • As far as peak fluctuations go, Biomarin Pharmaceutical's Asset Utilization Ratio tumbled by 1747.71% in 2021, and later skyrocketed by 1591.93% in 2024.
  • Over the past 5 years, Biomarin Pharmaceutical's Asset Utilization Ratio (Quarter) stood at 0.31 in 2021, then grew by 7.63% to 0.33 in 2022, then increased by 7.27% to 0.36 in 2023, then rose by 15.92% to 0.41 in 2024, then dropped by 0.44% to 0.41 in 2025.
  • Its Asset Utilization Ratio stands at 0.41 for Q3 2025, versus 0.42 for Q2 2025 and 0.42 for Q1 2025.